A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma

Figure 5

Decision curves for early recurrence in the training (a) and validation datasets. (b) The y-axis is the net benefit; the x-axis measures the threshold probability. The blue line indicates the net benefit for postulating patients with early recurrence, the black line indicates the net benefit for postulating patients without early recurrence, and the red line represents the expected net benefit of each patient based on the predictive model.

(a)

(b)